SEARCH

SEARCH BY CITATION

References

  • 1
    Whitacre, C. C., Sex differences in autoimmune disease. Nat. Immunol. 2001. 2: 777780.
  • 2
    Jansson, L., Olsson, T. and Holmdahl, R., Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice. J. Neuroimmunol. 1994. 53: 203207.
  • 3
    Bebo, B. F., Jr., Fyfe-Johnson, A., Adlard, K., Beam, A. G., Vandenbark, A. A. and Offner, H., Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J. Immunol. 2001. 166: 20802089.
  • 4
    Ito, A., Bebo, B. F., Jr., Matejuk, A., Zamora, A., Silverman, M., Fyfe-Johnson, A. and Offner, H., Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J. Immunol. 2001. 167: 542552.
  • 5
    Couse, J. F. and Korach, K. S., Estrogen receptor null mice: what have we learned and where will they lead us? Endocr. Rev. 1999. 20: 358417.
  • 6
    Polanczyk, M., Zamora, A., Subramanian, S., Matejuk, A., Hess, D. L., Blankenhorn, E. P., Teuscher, C. et al., The protective effect of 17beta-estradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptor-alpha. Am. J. Pathol. 2003. 163: 15991605.
  • 7
    Liu, H. B., Loo, K. K., Palaszynski, K., Ashouri, J., Lubahn, D. B. and Voskuhl, R. R., Estrogen receptor alpha mediates estrogen's immune protection in autoimmune disease. J. Immunol. 2003. 171: 69366940.
  • 8
    Garidou, L., Laffont, S., Douin-Echinard, V., Coureau, C., Krust, A., Chambon, P. and Guery, J. C., Estrogen receptor alpha signaling in inflammatory leukocytes is dispensable for 17beta-estradiol-mediated inhibition of experimental autoimmune encephalomyelitis. J. Immunol. 2004. 173: 24352442.
  • 9
    Confavreux, C., Hutchinson, M., Hours, M. M., Cortinovis-Tourniaire, P. and Moreau, T., Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N. Engl. J. Med. 1998. 339: 285291.
  • 10
    Sicotte, N. L., Liva, S. M., Klutch, R., Pfeiffer, P., Bouvier, S., Odesa, S., Wu, T. C. and Voskuhl, R. R., Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann. Neurol. 2002. 52: 421428.
  • 11
    Voskuhl, R. R. and Palaszynski, K., Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist 2001. 7: 258270.
  • 12
    Palaszynski, K. M., Loo, K. K., Ashouri, J. F., Liu, H. B. and Voskuhl, R. R., Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J. Neuroimmunol. 2004. 146: 144152.
  • 13
    Offner, H., Adlard, K., Zamora, A. and Vandenbark, A. A., Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis. J. Clin. Invest. 2000. 105: 14651472.
  • 14
    Fillmore, P. D., Blankenhorn, E. P., Zachary, J. F. and Teuscher, C., Adult gonadal hormones selectively regulate sexually dimorphic quantitative traits observed in experimental allergic encephalomyelitis. Am. J. Pathol. 2004. 164: 167175.
  • 15
    Dupont, S., Krust, A., Gansmuller, A., Dierich, A., Chambon, P. and Mark, M., Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 2000. 127: 42774291.
  • 16
    Maret, A., Coudert, J. D., Garidou, L., Foucras, G., Gourdy, P., Krust, A., Dupont, S. et al., Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor α expression in hematopoietic cells. Eur. J. Immunol. 2003. 33: 512521.
  • 17
    Delpy, L., Douin-Echinard, V., Garidou, L., Bruand, C., Saoudi, A. and Guery, J. C., Estrogen enhances susceptibility to experimental autoimmune myasthenia gravis by promoting type 1-polarized immune responses. J. Immunol. 2005. 175: 50505057.
  • 18
    Murphy, C. A., Hoek, R. M., Wiekowski, M. T., Lira, S. A. and Sedgwick, J. D., Interactions between hemopoietically derived TNF and central nervous system-resident glial chemokines underlie initiation of autoimmune inflammation in the brain. J. Immunol. 2002. 169: 70547062.
  • 19
    Plant, S. R., Wang, Y., Vasseur, S., Thrash, J. C., McMahon, E. J., Bergstralh, D. T., Arnett, H. A. et al., Upregulation of the stress-associated gene p8 in mouse models of demyelination and in multiple sclerosis tissues. Glia 2006. 53: 529537.
  • 20
    Ghezzi, A., Deplano, V., Faroni, J., Grasso, M. G., Liguori, M., Marrosu, G., Pozzilli, C. et al., Multiple sclerosis in childhood: clinical features of 149 cases. Mult. Scler. 1997. 3: 4346.
  • 21
    Weinshenker, B. G., Rice, G. P., Noseworthy, J. H., Carriere, W., Baskerville, J. and Ebers, G. C., The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 1991. 114 (Pt 2): 10451056.
  • 22
    Confavreux, C., Vukusic, S. and Adeleine, P., Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003. 126: 770782.
  • 23
    Bebo, B. F., Jr., Zelinka-Vincent, E., Adamus, G., Amundson, D., Vandenbark, A. A. and Offner, H., Gonadal hormones influence the immune response to PLP 139-151 and the clinical course of relapsing experimental autoimmune encephalomyelitis. J. Neuroimmunol. 1998. 84: 122130.
  • 24
    Papenfuss, T. L., Rogers, C. J., Gienapp, I., Yurrita, M., McClain, M., Damico, N., Valo, J. et al., Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains. J. Neuroimmunol. 2004. 150: 5969.
  • 25
    Tiwari-Woodruff, S., Morales, L. B., Lee, R. and Voskuhl, R. R., Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. Proc. Natl. Acad. Sci. USA 2007. 104: 1481314818.
  • 26
    Mo, R., Chen, J., Grolleau-Julius, A., Murphy, H. S., Richardson, B. C. and Yung, R. L., Estrogen regulates CCR gene expression and function in T lymphocytes. J. Immunol. 2005. 174: 60236029.
  • 27
    Reboldi, A., Coisne, C., Baumjohann, D., Benvenuto, F., Bottinelli, D., Lira, S., Uccelli, A. et al., C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 2009. 10: 514523.
  • 28
    Toutain, C. E., Filipe, C., Billon, A., Fontaine, C., Brouchet, L., Guery, J. C., Gourdy, P. et al., Estrogen receptor alpha expression in both endothelium and hematopoietic cells is required for the accelerative effect of estradiol on reendothelialization. Arterioscler. Thromb. Vasc. Biol. 2009. 29: 15431550.
  • 29
    Billon-Gales, A., Fontaine, C., Douin-Echinard, V., Delpy, L., Berges, H., Calippe, B., Lenfant, F. et al., Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice. Circulation 2009. 120: 25672576.
  • 30
    Nakai, K., Itoh, C., Hotta, K., Itoh, T., Yoshizumi, M. and Hiramori, K., Estradiol-17 beta regulates the induction of VCAM-1 mRNA expression by interleukin-1 beta in human umbilical vein endothelial cells. Life Sci. 1994. 54: PL221227.
  • 31
    Caulin-Glaser, T., Watson, C. A., Pardi, R. and Bender, J. R., Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J. Clin. Invest. 1996. 98: 3642.
  • 32
    Simoncini, T., Maffei, S., Basta, G., Barsacchi, G., Genazzani, A. R., Liao, J. K. and De Caterina, R., Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ. Res. 2000. 87: 1925.
  • 33
    Abu-Taha, M., Rius, C., Hermenegildo, C., Noguera, I., Cerda-Nicolas, J. M., Issekutz, A. C., Jose, P. J. et al., Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan. J. Immunol. 2009. 183: 13931402.
  • 34
    Roubinian, J., Talal, N., Siiteri, P. K. and Sadakian, J. A., Sex hormone modulation of autoimmunity in NZB/NZW mice. Arthritis Rheum. 1979. 22: 11621169.
  • 35
    Roubinian, J. R., Talal, N., Greenspan, J. S., Goodman, J. R. and Siiteri, P. K., Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J. Exp. Med. 1978. 147: 15681583.
  • 36
    Gourdy, P., Araujo, L. M., Zhu, R., Garmy-Susini, B., Diem, S., Laurell, H., Leite-de-Moraes, M. et al., Relevance of sexual dimorphism to regulatory T cells: estradiol promotes IFN-gamma production by invariant natural killer T cells. Blood 2005. 105: 24152420.
  • 37
    Kikuchi, S., Fukazawa, T., Niino, M., Yabe, I., Miyagishi, R., Hamada, T. and Tashiro, K., Estrogen receptor gene polymorphism and multiple sclerosis in Japanese patients: interaction with HLA-DRB1*1501 and disease modulation. J. Neuroimmunol. 2002. 128: 7781.
  • 38
    Niino, M., Kikuchi, S., Fukazawa, T., Yabe, I. and Tashiro, K., Estrogen receptor gene polymorphism in Japanese patients with multiple sclerosis. J. Neurol. Sci. 2000. 179: 7075.
  • 39
    Mattila, K. M., Luomala, M., Lehtimaki, T., Laippala, P., Koivula, T. and Elovaara, I., Interaction between ESR1 and HLA-DR2 may contribute to the development of MS in women. Neurology 2001. 56: 12461247.
  • 40
    Savettieri, G., Cittadella, R., Valentino, P., Manna, I., Andreoli, V., La Russa, A., La Porta, G. et al., Lack of association between estrogen receptor 1 gene polymorphisms and multiple sclerosis in southern Italy in humans. Neurosci. Lett. 2002. 327: 115118.
  • 41
    Thakker, P., Leach, M. W., Kuang, W., Benoit, S. E., Leonard, J. P. and Marusic, S., IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 2007. 178: 25892598.
  • 42
    Laffont, S., Coudert, J. D., Garidou, L., Delpy, L., Wiedemann, A., Demur, C., Coureau, C. and Guery, J. C., CD8+T-cell-mediated killing of donor dendritic cells prevents alloreactive T helper type-2 responses in vivo. Blood 2006. 108: 22572264.